(Q42808190)

7 November 2017

Alkylidene Oxapenem β-Lactamase Inhibitors Revisited: Potent Broad Spectrum Activity but New Stability Challenges (English)

1 reference

7 November 2017

10

Pravin S Shirude

1 reference

7 November 2017

Matthew D Miller

1

1 reference

7 November 2017

Manoj Kale

2

1 reference

7 November 2017

Kishore Reddy

3

1 reference

7 November 2017

Sharon Tentarelli

4

1 reference

7 November 2017

Mark Zambrowski

5

1 reference

7 November 2017

Minli Zhang

6

1 reference

7 November 2017

Tiffany Palmer

7

1 reference

7 November 2017

John Breen

8

1 reference

7 November 2017

Sushmita Lahiri

9

1 reference

7 November 2017

Jeroen C Verheijen

11

1 reference

7 November 2017

20 June 2014

1 reference

ACS Medicinal Chemistry Letters

7 November 2017

1 reference

7 November 2017

5

1 reference

7 November 2017

8

1 reference

7 November 2017

915-920

1 reference

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

The future of the β-lactams.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

New β-lactam antibiotics and β-lactamase inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Three decades of beta-lactamase inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

In vitro and in vivo activities of AM-112, a novel oxapenem.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

Synthesis and biological activity of AM-112 and related oxapenem analogues

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4137382

16 August 2018

Identifiers

DOI

10.1021/ML5001855

1 reference

7 November 2017

1 reference

7 November 2017

1 reference